Conference Call Scheduled for 4:30pm Eastern Time
NASDAQ, TSX: NVCN
VANCOUVER, March 13, 2019 /PRNewswire/ - Neovasc, Inc.
("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the
development of minimally invasive transcatheter mitral valve
replacement technologies and in the development of minimally
invasive devices for the treatment of refractory angina, today
announced that, due to the public offering of common stock
announced on March 12, 2019, it will
now report financial results for the year ended December 31, 2018 and host a conference call and
webcast at 4:30 pm Eastern Time on
Thursday, March 21, 2019.
Conference Call & Webcast
Thursday, March
21st @ 4:30pm Eastern Time
|
Domestic:
|
877-407-9208
|
International:
|
201-493-6784
|
Passcode:
|
13687733
|
Webcast:
|
http://public.viavid.com/index.php?id=133322
|
About Neovasc Inc.
Neovasc is a specialty
medical device company that develops, manufactures and markets
products for the rapidly growing cardiovascular marketplace. Its
products include the Reducer, for the treatment of refractory
angina, which is not currently commercially available in
the United States and has been
commercially available in Europe
since 2015, and the Tiara™, for the transcatheter treatment of
mitral valve disease, which is currently under clinical
investigation in the United
States, Canada and
Europe. For more information,
visit: www.neovasc.com.
View original
content:http://www.prnewswire.com/news-releases/neovasc-to-announce-year-ended-december-31-2018-financial-results-on-thursday-march-21-300812005.html
SOURCE Neovasc Inc.